Antibody Discovery

Antibody Discovery

Find the Right Antibody. From the Start

Antibody discovery is not a single technology. It's a series of decisions. Which diversity source? Which screening platform? Which molecular format? FairJourney Bio covers every route and runs them as one integrated workflow, so each lead is selected for developability from the start, never screened for binding and optimised later.

Discuss your programme

Find the Right Antibody. From the Start

Antibody discovery is not a single technology. It's a series of decisions. Which diversity source? Which screening platform? Which molecular format? FairJourney Bio covers every route and runs them as one integrated workflow, so each lead is selected for developability from the start, never screened for binding and optimised later.

Discuss your programme

Find the Right Antibody. From the Start

Antibody discovery is not a single technology. It's a series of decisions. Which diversity source? Which screening platform? Which molecular format? FairJourney Bio covers every route and runs them as one integrated workflow, so each lead is selected for developability from the start, never screened for binding and optimised later.

Discuss your programme

>1,400

projects completed

>250

global partners

>19

assets in clinical development

2

assets in Phase III

What our antibody discovery offering covers  

From the first target validation question to a fully characterised lead series ready for optimisation — FairJourney Bio's antibody discovery platform gives you the tools, the strategy, and the science to find what you need.

What our antibody discovery offering covers  

From the first target validation question to a fully characterised lead series ready for optimisation — FairJourney Bio's antibody discovery platform gives you the tools, the strategy, and the science to find what you need.

What our antibody discovery offering covers  

From the first target validation question to a fully characterised lead series ready for optimisation — FairJourney Bio's antibody discovery platform gives you the tools, the strategy, and the science to find what you need.

Our antibody discovery solutions

Three integrated platforms — each designed for a specific discovery challenge, all connected through FairJourney Bio's integrated workflow.

MultiPath Discovery 

A format-agnostic platform for fully customisable discovery strategies. Any target, any format — configured around your Target Product Profile from day one. Includes access to FairJourney Bio's proprietary Cosmic and SuperHuman 2.0 libraries, all four display platforms, and two specialist services: CellCraft Solutions for cell line engineering and FunctionInsight Assays for functional characterisation.

BCell Navigator

Dual-engine single B-cell screening that searches the complete immune repertoire — Memory B cells and Plasma cells — in parallel. Delivers a qualified, functionally screened hit panel in 8–10 weeks. The only platform in the industry that screens both B-cell populations without compromise.

DeepDesign Engineering 

Multi-parameter antibody optimisation from lead to best-in-class candidate. Library-based, in silico, and structure-guided approaches — including the proprietary Tumbler platform for simultaneous affinity maturation, humanisation, and cross-reactivity induction in as little as 4 months.

Why FairJourney Bio for antibody discovery

Strategy before science

Every campaign starts with a strategy designed around your target biology and Target Product Profile — not a default workflow. The platform, the library, and the format are selected to maximise your probability of delivering a clinical candidate.

Proprietary libraries built for the clinic

The Cosmic Library (100 billion clones) and SuperHuman 2.0 (76 billion clones) are exclusive to FairJourney Bio. Developability is hardwired into the diversity — so the hits you advance are already fit for clinical development. No licensing. No competitor access.

Fully integrated — no handoffs

Hits from discovery move directly into engineering, characterisation, manufacturing, and IND filing under the same project lead with full data continuity. No re-learning curve. No translation loss between partners.

Proven at scale

More than 1,400 projects completed. More than 250 global partners. 19 assets in clinical development. The experience to know what works — and why.

Why FairJourney Bio for antibody discovery

Strategy before science

Every campaign starts with a strategy designed around your target biology and Target Product Profile — not a default workflow. The platform, the library, and the format are selected to maximise your probability of delivering a clinical candidate.

Proprietary libraries built for the clinic

The Cosmic Library (100 billion clones) and SuperHuman 2.0 (76 billion clones) are exclusive to FairJourney Bio. Developability is hardwired into the diversity — so the hits you advance are already fit for clinical development. No licensing. No competitor access.

Fully integrated — no handoffs

Hits from discovery move directly into engineering, characterisation, manufacturing, and IND filing under the same project lead with full data continuity. No re-learning curve. No translation loss between partners.

Proven at scale

More than 1,400 projects completed. More than 250 global partners. 19 assets in clinical development. The experience to know what works — and why.

Why FairJourney Bio for antibody discovery

Strategy before science

Every campaign starts with a strategy designed around your target biology and Target Product Profile — not a default workflow. The platform, the library, and the format are selected to maximise your probability of delivering a clinical candidate.

Proprietary libraries built for the clinic

The Cosmic Library (100 billion clones) and SuperHuman 2.0 (76 billion clones) are exclusive to FairJourney Bio. Developability is hardwired into the diversity — so the hits you advance are already fit for clinical development. No licensing. No competitor access.

Fully integrated — no handoffs

Hits from discovery move directly into engineering, characterisation, manufacturing, and IND filing under the same project lead with full data continuity. No re-learning curve. No translation loss between partners.

Proven at scale

More than 1,400 projects completed. More than 250 global partners. 19 assets in clinical development. The experience to know what works — and why.

Not sure which discovery approach is right for your target? Our scientific team will help you design the right strategy.

Talk to our team

Explore discovery-to-IND

Not sure which discovery approach is right for your target? Our scientific team will help you design the right strategy.

Talk to our team

Explore discovery-to-IND

Not sure which discovery approach is right for your target? Our scientific team will help you design the right strategy.

Talk to our team

Explore discovery-to-IND

Fullspectrum Characterization

fullspectrum-characterization

0

AnyFormat Manufacturing

anyformat-manufacturing

0

DeepDesign Engineering

deepdesign-engineering

0

FunctionInsight Assays

functioninsight-assays

0

B-Cell Navigator

b-cell-navigator

0

Solutions

solutions

1

Platforms & Technologies

platforms-technologies

0

Why FJBio

why-fjbio

0

Events & Resources

events-resources

0

Company

company

0

About

about

0

Antibody Discovery

antibody-discovery

0

Protein Production

protein-production

0

AtomicLevel Cryo-EM

atomic-level-cryo-em

0

FastTrack IND

fasttrack-ind

0

Biologistics

biologistics

0

Leadership

leadership

0

Careers

careers

0

News & Insights

news-insights

0

Case Studies

case-studies

0

Fact Sheets

fact-sheets

0

CellCraft Solutions

cellcraft-solutions

0

Cryo-EM

cryo-em

0

Display Platforms

display-platforms

0

Events

events

0

Library Diversity

library-diversity

0

MultiPath Discovery

multipath-discovery

0

Publications & Posters

publications-posters

0

Resources

resources

0

Screening | Analytics | Data Engines

screening-analytics-data-engines

0

Single B-Cell Screening

single-b-cell-screening

0

The Antibody Series Conference

the-antibody-series-conference

0

Tumbler™

tumbler

0

Webinars

webinars

0

White papers

whitepapers

0

Contact Us

contact-us

0